Choosing between TelosRX and Omzo for GLP-1 weight loss comes down to what you pay in month two and what the rate includes. Omzo advertises compounded semaglutide from $179 a month and compounded tirzepatide from $279, both as once-weekly injections. Its published terms then list follow-up packages at $299 and $399. TelosRX starts as low as $99 per month for semaglutide, holds that rate flat as your dose is titrated, includes quarterly labs, and charges nothing unless a licensed provider approves you. Both companies display a LegitScript seal, and both are clear that compounded medications are not FDA-approved.
Want a broad wellness platform that names its physicians, advertises a money-back guarantee, and can route you toward brand-name medication? Omzo is a credible option. Want one rate that does not climb after month one, a needle-free path, quarterly labs, a named pharmacy, and no charge until a provider says yes? TelosRX is the better fit.
Start your intake →Quick comparison: TelosRX vs Omzo
Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is never guaranteed. Pricing and program details are as published by each company at the time of writing.
What is TelosRX?
TelosRX is an online-first, LegitScript-certified telehealth service built around GLP-1 weight management. It works asynchronously. You complete a short intake, a US-licensed provider reviews it, and there is no appointment to book at any point in the process.
The GLP-1 line covers four paths rather than one. Injectable semaglutide is the entry point at as low as $99 per month. Injectable tirzepatide is as low as $139 per month. There is a needle-free daily oral GLP-1 from $9 a day. For a gentler start, microdosed tirzepatide runs as low as $116 per month. All four sit side by side on the GLP-1 options page.
Every plan includes unlimited messaging with a 24/7 care team, dose adjustments as your body responds, quarterly labs, and free 2-day discreet shipping. Your rate stays flat as your dose is titrated. If a licensed provider decides a GLP-1 is not right for you, you pay nothing and nothing ships.
Medications are compounded by licensed US pharmacies, and TelosRX names them publicly: VialsRX and Jungle Jim's. Clinical care is delivered through Arora Health Group. You can start your evaluation without booking an appointment.
What is Omzo?
Omzo, at omzo.com, is a personalized telehealth platform that spans weight loss, women's hormone health, sexual health, hair, skin, and daily supplements. Weight loss is one program inside a much wider consumer wellness catalog.
The weight-loss program is built on two compounded medications. Compounded semaglutide is listed from $179 a month and compounded tirzepatide from $279, and both are described as one simple injection per week. Omzo runs a welcome offer of $120 off the first month on its program page.
Omzo is unusually direct about what compounded medication is. Its footer states plainly that compounded drugs are not FDA-approved and that the FDA has not reviewed them for safety, effectiveness, or quality. It also states plainly that Omzo is not a medical practice or a pharmacy. That level of disclosure is not universal in this category, and it deserves credit.
Its program pages name three partner physicians with their credentials, including a board-certified doctor of osteopathic medicine and a physician certified by the American Board of Emergency Medicine. Omzo also advertises a money-back guarantee for eligible programs. It displays a LegitScript seal in its footer and publishes a HIPAA privacy policy.
Medications: what each program offers
Both services work in the same drug class. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both the GLP-1 and the GIP receptor. Both slow gastric emptying and act on appetite signaling, which is the mechanism behind reduced hunger and smaller portions. If you are weighing the two molecules, our guide to tirzepatide versus semaglutide walks through the difference.
The compounded versions offered by both TelosRX and Omzo are not FDA-approved. They are prepared by licensed US compounding pharmacies under provider supervision. Omzo states this repeatedly across its site, which is the right way to handle it.
The practical difference is format and choice. Omzo publishes two routes, and both are weekly injections. TelosRX publishes four, including a daily under-the-tongue option that removes needles from the routine entirely, plus a microdosed tirzepatide protocol for people who want to ease in gently. If needles are the thing standing between you and starting, you can begin a needle-free oral GLP-1 now.
Omzo does publish one thing TelosRX does not. Its terms list packages for brand-name Ozempic and Zepbound at $1,299 and $1,399, described as available on a limited basis. Its footer separately notes that patients may be responsible for filling a branded prescription at a pharmacy of their choosing. If a brand-name product is what you want, ask Omzo how that route works before you enroll.
For background on this drug class, see the NIH NIDDK overview of prescription weight-management medications and the FDA's questions and answers on drug compounding.
Key takeaway: Omzo's advertised entry rates of $179 and $279 are first-month figures. Its own terms list follow-up packages at $299 and $399. TelosRX publishes one rate per medication and holds it through titration, with quarterly labs included.
Pricing and what the rate covers
Omzo publishes prices on its product cards, which deserves credit in a category where many rivals gate the number behind a quiz. Compounded semaglutide is shown from $179 a month and compounded tirzepatide from $279. A welcome offer of $120 off the first month appears on the weight-loss program page.
The number worth reading carefully sits in the terms and conditions. There Omzo lists an initial GLP-1 consultation package and a separate follow-up package at $299, plus an initial GLP-1 and GIP package and a follow-up at $399. Figures differ between Omzo's marketing pages and its terms, so confirm the ongoing monthly rate at checkout before you commit.
TelosRX takes the other approach and publishes four rates that do not move:
- Semaglutide, injectable, as low as $99 per month
- Microdosed tirzepatide, as low as $116 per month
- Tirzepatide, injectable, as low as $139 per month
- Oral GLP-1, needle-free and daily, from $9 a day
Set the two side by side on semaglutide. Omzo advertises from $179, with its terms listing a $299 follow-up package. TelosRX is as low as $99 and stays there as your dose climbs. On tirzepatide the gap is wider still, with Omzo advertising from $279 against a TelosRX rate as low as $139.
Neither company bills insurance, and both mark their plans as FSA and HSA eligible. Omzo says its price includes the medication, the consultation, shipping, and support. The TelosRX rate covers the medication, provider review, dose adjustments, quarterly labs, unlimited messaging, and free 2-day shipping. Start your intake to see your plan price in a few minutes.
How the process works
Both companies keep the front door simple. Omzo describes a health assessment of about two minutes, followed by clinician review and a personalized plan, with medication shipped to your door and refills handled online. Its shipping policy adds an important detail. State regulations determine whether the review requires an online consultation, so the experience is not identical everywhere.
With TelosRX, the intake takes about five minutes, a licensed provider reviews it asynchronously in every state, and approved medication ships free with 2-day delivery. Nothing is charged unless you are approved, and if a provider declines you, you pay nothing at all.
That difference matters at the payment step. Omzo takes payment up front and its terms provide a refund when a provider determines you are not medically eligible, requested in writing within 28 days of payment. Once the medical intake is submitted, its terms describe the order as processed and non-refundable. Omzo publishes more than one refund policy across its site, so check which one applies to the page you enrolled through.
On delivery, Omzo's terms say medication ships within 48 business hours of approval, and its shipping policy describes roughly four to seven business days to your door. It also commits to a full refund if your medication has not shipped within 14 business days, which is a fair and concrete promise. Begin your TelosRX intake and a licensed provider will review it.
Coaching and ongoing support
Neither company sells a heavy coaching curriculum. Support in both cases means access to clinical people, plus tools that help you stay consistent.
Omzo leans on its app. Members message the care team, track progress, get weekly check-ins, and manage refills in one place. The program page also points to an Omzo community group. A support phone line is published on its shipping policy page. What the site does not publish is a lab program, so bloodwork is something you would arrange elsewhere.
TelosRX includes unlimited messaging with a 24/7 care team, dose adjustments as your body changes, and quarterly labs. If tracking your bloodwork alongside the medication matters to you, that is a real difference rather than a marketing one. You can also read the rest of our GLP-1 guides before you decide.
Safety, oversight, and disclosure
Both companies gate medication behind a licensed prescriber, and both say so clearly. GLP-1 medications are not appropriate for everyone. Nausea and digestive changes are common early on with either medication. A provider should review your history, your current medications, and any personal or family history of thyroid cancer.
Omzo's disclosure is a genuine strength. Its footer states that compounded medications are not FDA-approved and that results are not guaranteed. It names partner physicians with their credentials. Both companies display a LegitScript seal, so certification is not a point of difference between them. LegitScript's own verification tool is the reliable place to confirm the current status of any telehealth company.
Where the two diverge is the supply chain. Omzo describes its pharmacy as an independent, state-licensed compounding pharmacy and its clinicians as third-party networks, without naming either. TelosRX names VialsRX and Jungle Jim's for pharmacy and Arora Health Group for clinical care. If knowing exactly who compounds your medication matters to you, ask Omzo for the pharmacy name before you enroll.
Ready to compare in practice rather than on paper? Check your eligibility in about five minutes.
Which service is right for you?
Best for a rate that stays flat after month one, a needle-free daily option, quarterly labs, a named pharmacy and provider group, and paying nothing unless a provider approves you.
Best for one platform that also covers hormone health, sexual health, hair, skin, and daily supplements, with named partner physicians, an advertised money-back guarantee, and a published route toward brand-name medication.
If you are choosing on price stability, needle-free access, lab monitoring, supply-chain transparency, or not paying before approval, TelosRX is the stronger fit. If you want your weight care bundled with hair, skin, hormone, and supplement programs under one login, and a results guarantee matters to you, Omzo earns a serious look.
Frequently Asked Questions
Is TelosRX legitimate?
Yes. TelosRX is a LegitScript-certified telehealth service. Medications are compounded by licensed US pharmacies, VialsRX and Jungle Jim's, and clinical care is provided through Arora Health Group. Every prescription is subject to medical approval by a licensed provider.
How much does TelosRX cost compared to Omzo?
TelosRX publishes four rates that stay flat as your dose is titrated. Semaglutide is as low as $99 per month, microdosed tirzepatide as low as $116, injectable tirzepatide as low as $139, and needle-free oral GLP-1 from $9 a day. Omzo advertises compounded semaglutide from $179 a month and compounded tirzepatide from $279, and its terms list follow-up packages at $299 and $399.
Does Omzo offer a needle-free GLP-1?
Its published weight-loss lineup lists compounded semaglutide and compounded tirzepatide as once-weekly injections, with no oral GLP-1 shown. TelosRX offers a needle-free daily oral GLP-1 from $9 a day, alongside injectable semaglutide, injectable tirzepatide, and a microdosed tirzepatide option.
Are the GLP-1 medications FDA-approved?
No. The compounded semaglutide and tirzepatide offered by both TelosRX and Omzo are not FDA-approved. They are prepared by licensed US compounding pharmacies under provider supervision, and only a licensed provider can decide whether a compounded medication is appropriate for you.
Do you pay Omzo before a provider reviews you?
Yes. Omzo takes payment up front, and its terms provide a full refund if a provider determines you are not medically eligible, requested in writing within 28 days of payment. Once the medical intake is submitted, the order is described as processed and non-refundable. TelosRX charges nothing unless a licensed provider approves you.
Can I switch from Omzo to TelosRX?
Many people compare programs before deciding. You can start a new TelosRX intake at any time. A provider reviews your history, current medications, and goals before anything is approved, and you pay nothing if a provider decides a GLP-1 is not right for you.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Any prescription is subject to evaluation by a licensed provider, and approval is never guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service. Competitor details are as published on omzo.com at the time of writing and may change.
Start your private evaluation at TelosRX, or compare every plan on the GLP-1 options page.